FDA grants accelerated approval for Novartis's Vanrafia (atrasentan) for IgA nephropathy. The drug joins Tarpeyo and Filspari ...
Sarepta and Roche are hitting the brakes on three trials of their Duchenne gene therapy Elevidys in response to a request by the European Medicines Agency.
A few cell and gene therapy biotechs are doing alright this week. The latest is Neurona Therapeutics, which exclusively told ...
A rapid cascade of seemingly conflicting details from President Donald Trump’s tariff announcement left large drugmakers on ...
President Donald Trump on Wednesday announced broad global tariffs, including a 20% tariff on Europe, in a move that pharma ...
The FTC’s legal fight against three major pharmacy benefit managers is on hold after two agency commissioners have been ...
Eli Lilly’s direct-to-consumer service added knownwell to its line-up of providers who can prescribe its medications, as it ...
The European Medicines Agency is looking to simplify the way it approves biosimilars by removing the need for “extensive” clinical data, which would likely cut the cost of entry into the market.
BIO CEO John Crowley sat down for an exclusive interview that covered tariffs, collaborating with RFK Jr., and investing in ...
Tang Capital’s shell company Concentra Biosciences secured its first major deal since late 2023. Allakos has agreed ...
Sanofi pays $15M to license Nurix autoimmune program. Sumitomo transfers Asia units. Gilead cuts 149 jobs, Roche 108 in ...
The HHS and other federal agencies must reverse the terminations of probationary government workers that were fired in the states challenging the cuts, under a new order issued Tuesday by a federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback